Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1995-02-03
1997-11-04
Rories, Charles C. P.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536 231, 536 251, 536 255, 435375, 4242801, A61K 4800, A61K 31785, A61K 3180, C07H 2102
Patent
active
056839863
ABSTRACT:
Parenterally administered systemic dsRNAs release host mediators into various compartmentalized biological fluids to combat various microorganisms, particularly viruses, thereby reducing the infectivity and spread of various organisms including those associated with various diseases such as those caused by venereal warts, herpes and HIV.
REFERENCES:
patent: 3931397 (1976-01-01), Harnden
patent: 4140761 (1979-02-01), Gerin et al.
patent: 4795744 (1989-01-01), Carter
patent: 4820696 (1989-04-01), Carter
R. Suhodolnik et al., Clinical Infecious Diseases vol. 18, Suppl. 1:S 96-S 104 1994.
D. Strayer et al., J. of Chronic Fatigue Syndrome vol. 1(1):35-53 1995.
D. Drutz et al., in Basic & Clinical Immunol., Ed. by D. Stites, J. Sroho, et al., Lange Medical Publications, Los Altos, CA ('84) pp. 197-222.
Nature, vol. 242, No. 5399, Apr. 20, 1987, pp. 525-526, M. Koltai et al "Inhibition of the Acute Inflammatory Response by Interferon Inhibitors".
The Lancet, Jun. 6, 1987, pp. 1286-1292, Carter et al. "Clinical Immunological and Virological Effects of Ampligen . . . ".
Journal of Biological Response Modifiers, vol. 4, 1985, pp. 669-675 I. Brodsky et al "Clinical Studies with Ampligen . . . ".
Journal of Biological Response Modifiers, vol. 4, 1985, pp. 495-502 Carter et al, "Preclinical Studies with Ampligen . . . ".
Springer Semin. Immunopathol., vol. 2, 1979, pp. 149-168, Johnson "Modulation of the Immune System by Synthetic Polynucleotides".
Handbook of experimental Pharmacology, vol. 71, pp. 536-555, Came et al "Therapeutic Applications of Double-Stranded RNAs".
Mol. Pharmacol., vol. 12, No. 2, 1976, pp. 299-312, P. TS'O et al "An Integrated and Comparative Study of the Antiviral Effects and . . . ".
Hemispherx Biopharma Inc.
Rories Charles C. P.
LandOfFree
Elaboration of host defense mediators into biological fluids by does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Elaboration of host defense mediators into biological fluids by , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Elaboration of host defense mediators into biological fluids by will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1833084